Duloxetine Recall May 2024. The medication, produced by towa. โ€œa situation in which use of or exposure to a violative product may cause.


Duloxetine Recall May 2024

Fda issued a class ii recall for the antidepressant duloxetine, manufactured by towa pharmaceutical europe, after detecting nitrosamine impurities, which are known carcinogens. The recall involves 7,107 bottles of duloxetine, which is sold under the brand name cymbalta by max molski โ€ข published october 24, 2024 โ€ข updated on october 24, 2024.

Duloxetine Recall May 2024 Images References :